As an OEM company for syringe manufacturing, we contribute to the global "medical field."
Kinko Medics Co., Ltd. specializes in the manufacturing of medical special injection needles and sells them widely to domestic and overseas medical device manufacturers based on OEM. With the quality basic policy of "providing products that customers can trust," we are constantly focused on needle manufacturing, aiming to reduce puncture resistance for less invasive procedures, improving our core grinding technology, conducting risk management activities in needle manufacturing derived from FMEA activities, and accumulating evidence that our needles are safe. We are always striving to produce products that our customers can trust. Furthermore, we continuously challenge ourselves with new technologies, looking three to five years ahead, and aim to be a company that our customers can rely on by transforming what seems impossible into possible. For more details, please contact us or download our catalog.
Inquire About This Product
basic information
【Product Items】 ○ Needle with hole for venous catheterization ○ AVF needle for artificial dialysis ○ Needle for blood bags for blood donation ○ Epidural needle ○ Spinal needle ○ Biopsy needle ○ Bone marrow needle ○ Dual-ended needle for vial rubber puncture ○ Other various special-purpose needles ● For more details, please contact us or download the catalog.
Price information
Please contact us.
Delivery Time
※Please contact us.
Applications/Examples of results
For more details, please contact us or download the catalog.
catalog（1）
Download All Catalogs
Company information
Kinko Medics Co., Ltd. specializes in the manufacturing of medical special injection needles and sells them widely to domestic and overseas medical device manufacturers based on OEM. With the quality basic policy of "providing products that customers can trust," we are constantly focused on needle manufacturing, aiming to reduce puncture resistance for minimally invasive procedures, improving our core grinding technology, engaging in risk management activities in needle manufacturing derived from FMEA activities, and accumulating evidence that our needles are safe. We are always looking three to five years ahead, continuously challenging ourselves with new technologies, and even if something cannot be done immediately, we strive to transform the impossible into the possible, aiming to be a company that customers can rely on.